Madison Louder
Analyst
B. Riley Securities
Equibles does not estimate personal net worth.
About Madison Louder
Madison Louder is recorded as Analyst at B. Riley Securities. Madison Louder has spoken on 1 earnings call across 1 company, most recently for Vanda Pharmaceuticals Inc. on October 28, 2026. The companies whose calls Madison Louder spoke on are classified in the Healthcare sector.
Madison Louder on recent calls
“Do you expect the GLP-1 label to restrict NARIAs to the titration phase or permit more of a chronic dosing throughout maintenance? And I'm really just curious, you know, is it possible that the SNDA positioning Narius to support starting at the target GLP-1 dose versus at the titration dose?”
Affiliation history
-
B. Riley Securities
Analyst
Transcript header (unverified)
Current